Overview of current clinical registries

ATTRA

Multicentric system for the assessment of the progress and results of biological therapy of ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus.

BIOMARKERY PANKREAS

Evaluation of efficacy of new spectroscopic biomarkers for the detection of early-stage pancreatic cancer.

CAMELIA – Chronic MyEloid LeukaemIA

International clinical registry of patients with chronic myeloid leukaemia.

Cervix.cz – Cervical Cancer Screening Programme in the Czech Republic

System of informational support for the Cervical Cancer Screening Programme in the Czech Republic.

CHOPIN – Chronic pain neuromodulation

Clinical registry of neuromodulation techniques applied in patients suffering from chronic pain.

CHOPN

Non-interventional multicentre observational prospective database focusing on the collection and analysis of data on real mortality and morbidity in an unselected population of COPD patients.

CLLEAR

Clinical registry of patients with chronic lymphocytic leukaemia (CLL).

CREDIT – Czech registry of IBD patients on biological therapy

Non-interventional multicentre retrospective and prospective longitudinal monitoring of patients with inflammatory bowel disease (IBD) who have been treated with biological therapies.

CyRUS – Cystectomy Registry of the Czech Urological Society

Clinical registry monitoring cases of bladder cancers treated with cystectomy and consecutive treatment.

Czech National Haemophilia Programme (CNHP)

The Czech National Haemophilia Programme (CNHP) is a non-interventional multicentre prospective study which monitors inherited haemorrhagic disorders: haemophilia, von Willebrand's disease and other haemorrhagic disorders.

DATOOL ALL

Clinical registry of patients with acute lymphoblastic leukaemia (ALL).

DATOOL AML

Clinical registry of patients with acute myeloid leukaemia (AML).

DoIT!

Non-interventional, multicentre, retrospective and prospective study of patients with brain tumours, who have been treated in the Czech Republic according to the common clinical practice.

EMPIRE

Clinical registry of patients with idiopathic pulmonary fibrosis (IPF).

EndoMAZE HYBRID

Detailed assessment of safety and efficacy of hybrid ablation of persistent and long-standing persistent atrial fibrillation using a combined (hybrid) approach – surgical thoracoscopic epicardial ablation and a subsequent complex cardiological endocardial ablation.

EPOSS

Multicentre research database for implementation of parametric monitoring of severe sepsis treatment directly in clinical practice.

FAP – Familial Adenomatous Polyposis

FIND

Clinical registry of haemato-oncological patients in which antimycotic therapy has been administered.

HARM

Multicentre, non-interventional, retrospective and prospective monitoring of patients with chronic HCV infection who have been treated with direct-acting antiviral agents (DAAs) or with standard therapy.

IKTA.CZ

Nationwide registry of stroke patients: a non-interventional multicentre prospective study.

Infinity

Clinical registry of patients with chronic myeloid leukaemia (CML).

KARDIO-ICD – Registry of implantable cardioverter-defibrillators (ICD)

A central registry dealing with the implantation of implantable cardioverter-defibrillators (ICD).

KATAB – Registry of catheter ablations

A central registry dealing with catheter ablations.

KELLY

Registry of EGFR mutation testing results in patients with non-small-cell lung cancer (NSCLC) in the Czech Republic.

Kolorektum.cz – Colorectal Cancer Screening Programme in the Czech Republic

System of informational support for the Colorectal Cancer Screening Programme in the Czech Republic.

Mamo.cz – Breast Cancer Screening Programme in the Czech Republic

System of informational support for the Breast Cancer Screening Programme in the Czech Republic.

MDS – MyeloDysplastic Syndrome

Clinical registry of patients with myelodysplastic syndrome.

Melanom

Clinical registry of melanoma patients who have been treated with dabrafenib (Tafinlar®), ipilimumab (Yervoy®), nivolumab (Opdivo®), trametinib (Mekinist®), pembrolizumab (Keytruda®) and/or vemurafenib (Zelboraf®).

MIND

Clinical registry of patients with myeloproliferative disorders.

MyReg – MYasthenia gravis REGistry

Registry collecting data on patients with myasthenia gravis, a rare autoimmune neuromuscular disorder

NET – NEuroendocrine Tumours

Český registr neuroendokrinních nádorů.

OBAAMA-INT

Prospective observational multinational multicentre study aiming to cover all health care facilities providing anaesthesia in the peripartal period in the Czech Republic and Slovakia, thus getting the most accurate image possible about this segment of anaesthesiology.

PID – primary immunodeficiency database

Non-interventional, multicentre, prospective study monitoring the development and treatment of congenital dysfunctions of the immune system.

Prague 18

Randomised trial comparing the effectiveness of ticagrelor and prasugrel in patients with ST segment elevation myocardial infarction (STEMI) who have been treated with primary PCI.

ReACH – Achondroplasia Registry

Clinical registry of patients with achondroplasia.

REaDY – REgistry of muscular DYstrophies

REaDY (REgistry of muscular DYstrophies) is a clinical registry of patients suffering from Duchenne/Becker's muscular dystrophy (DMD/BMD), spinal muscular atrophy (SMA), myotonic dystrophy (DM) or facioscapulohumeral muscular dystrophy (FSHD).

REPACE – Registry of pacemakers

A central registry dealing with the implantation of pacemakers.

REPAR

Czech nationwide registry of patients who have been treated with growth hormone.

REPLY

Clinical registry focused on non-interventional monitoring of patients with pulmonary hypertension.

RMG – Registry of Monoclonal Gammopathies

International clinical registry of patients with monoclonal gammopathies.

SONAR

Registry of patients with first acute ischaemic stroke of the carotid circulation with permanent neurological deficit.

TAVI

Clinical registry collecting data on patients who have undergone transcatheter aortic valve implantation (TAVI).

Tulung

Clinical registry of non-small cell lung cancer (NSCLC) patients who have been treated with bevacizumab (Avastin®), erlotinib (Tarceva®), gefitinib (Iressa®), pemetrexed (Alimta®), afatinib (Giotrif®) and/or nintedanib (Vargatef®).